Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 057953/0190 | |
| Pages: | 8 |
| | Recorded: | 10/28/2021 | | |
| Attorney Dkt #: | C4019.10002US06 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17125776
|
Filing Dt:
|
12/17/2020
|
|
Publication #:
|
|
Pub Dt:
|
04/08/2021
| | | | |
|
Title:
|
DRUG DELIVERY SYSTEMS COMPRISING A NEUROTROPHIC AGENT, AN APOPTOSIS SIGNALING FRAGMENT INHIBITOR (FAS) OR FAS LIGAND (FASL) INHIBITOR, A TUMOR NECROSIS FACTOR-ALPHA (TNF-ALPHA) OR TNF RECEPTOR INHIBITOR, A MITOCHONDRIAL PEPTIDE, AN OLIGONUCLEOTIDE, A CHEMOKINE INHIBITOR, OR A CYSTEINE-ASPARTIC PROTEASE INHIBITOR
|
|
|
Assignee
|
|
|
|
|
| 1970 TEMPLE HILLS DRIVE |
| LAGUNA BEACH, CALIFORNIA 92651 |
|
|
Correspondence name and address
|
| |
MASCHOFF BRENNAN
|
| |
1389 CENTER DRIVE, SUITE 300
|
| |
PARK CITY, UT 84098
|
Search Results as of:
06/04/2024 02:43 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
